Skip to content

Clinical trials

Completed Phase 2 Liver Cirrhosis, Biliary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis, Biliary Phase: Phase 2 Status: Completed Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20071
20081
20101
20111
20121
20132
20143
20151
20161
20176
20212
20224
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Intercept Pharmaceuticals3
GlaxoSmithKline2
NGM Biopharmaceuticals, Inc2
Calliditas Therapeutics AB1
Calliditas Therapeutics Suisse SA1
Enanta Pharmaceuticals, Inc1
Escient Pharmaceuticals, Inc1
Gannex Pharma Co., Ltd.1
Genfit1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis, Biliary27
Pruritus4
Cholestasis2
Biliary Atresia1
Biliary Tract Diseases1
Cholangitis1
Cholangitis, Sclerosing1
Cholestasis, Intrahepatic1
Fatigue1
Fibrosis1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.